Chemotherapy Induced Peripheral Neuropathy Treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025- Increased prevalence of cancer coupled with increased demand of chemotherapy agents is likely to grow the chemotherapy induced peripheral neuropathy treatment market.
Chemotherapy Induced Peripheral Neuropathy Treatment Market is valued at USD 1305.32 Million in 2018 and expected to reach USD 1789.62 Million By 2025 with the CAGR of 5.4% over the forecast period.
Chemotherapy is a chemical treatment which is used for the treatment of cancer it involves the administration of drugs which destroys the cancerous cells and helps in the treatment. These drugs are made up of various chemicals such as platinum agents, opioids, alkaloids and others. Peripheral neuropathy affects the nerves outside the brain which carries the electrical signal such as pain and others which causes weakness, numbness and it usually occurs in hands and feet. The long term use of various chemotherapy agents is responsible for the chemotherapy induces peripheral neuropathy as a side effect of chemotherapy in the cancer patient.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=65812&RequestType=Sample
Chemotherapy Induced Peripheral Neuropathy Treatment Market report is segmented on type, application and by regional & country level. Based upon type, chemotherapy induced peripheral neuropathy treatment market is segmented into Calcium Channel a2-delta Ligands, Antidepressants, Opioids, and Others. Based upon application, chemotherapy induced peripheral neuropathy treatment market is classified into Platinum Agents, Taxanes, Vinca Alkaloids, and Others.
The regions covered in this Chemotherapy Induced Peripheral Neuropathy Treatment market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Chemotherapy Induced Peripheral Neuropathy Treatment market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Chemotherapy Induced Peripheral Neuropathy Treatment Market Reports–
Some major key players for Chemotherapy Induced Peripheral Neuropathy Treatment market are Asahi Kasei Pharma, Aptinyx, Regenacy Pharmaceuticals, MAKScientific, Metys Pharmaceuticals, PledPharma, Apexian Pharma, Sova Pharmaceuticals, Immune Pharmaceuticals, DermaXon, Nemus Bioscience, Kineta, Krenitsky Pharmaceuticals, WinSanTor, PeriphaGen, and Solasia Pharma among others.
News–
In April 2018, Kineta Chronic Pain, LLC, a subsidiary of Kineta, Inc., has announced that it has entered into an exclusive option and license agreement with Genentech, a member of the Roche Group, to develop Kineta’s α9/α10 nicotinic acetylcholine receptor (nAChR) antagonists for the treatment of chronic pain.
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=65812&RequestType=Methodology
Increased prevalence of cancer coupled with increased demand of chemotherapy agents is the key factor which helps Chemotherapy Induced Peripheral Neuropathy Treatment Market to grow.
Over the period of time there has been tremendous growth in the prevalence of different cancer and chemotherapy is the mostly used treatment options for the cancer patient apart from surgery. Most of the cases are late stage diagnosis and which makes the treatment difficult for both patient and healthcare professionals. As per Cancer Research UK 2018 report, there were around 17 million new cancer cases has been reported on a global level. The increased prevalence of cancer and late stage diagnosis has increased the demand for chemotherapy from the past few years which is expected to fuel the growth of chemotherapy induced peripheral neuropathy treatment market. Furthermore, huge product pipeline coupled with late stage clinical trials are expected to promote the growth of chemotherapy induced peripheral neuropathy treatment market. Moreover, increasing research and development activities coupled with collaborations among market players are expected to create ample opportunities in the chemotherapy induced peripheral neuropathy treatment market. However, high cost of advanced chemotherapy drugs are expected to hamper the growth of chemotherapy induced peripheral neuropathy treatment market in near future.
North America is expected to dominate the Chemotherapy Induced Peripheral Neuropathy Treatment Market.
North America is expected to account for the major market share owing to the presence of developed countries such as U.S., Canada and others. Moreover, increased prevalence of cancer coupled with presence of developed healthcare infrastructure. Europe is expected to account for the second largest market share over the forecast owing to the increasing research and development activities coupled with increasing clinical trials are further expected to promote the growth of chemotherapy induced peripheral neuropathy treatment market. Asia Pacific is expected to develop significantly and maintain its dominance over the forecast period. The presence of developing economies such as India, China and others coupled with increased prevalence of cancer and increasing disposable income and increasing public awareness are further expected to anticipate the growth of chemotherapy induced peripheral neuropathy treatment market over the forecast period. Middle East, Latin America and Africa are expected to develop considerably in the near future.
Key Benefits for Chemotherapy Induced Peripheral Neuropathy Treatment Market Reports –
Global market report covers in depth historical and forecast analysis.
Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global market report helps to identify opportunities in market place.
Global market report covers extensive analysis of emerging trends and competitive landscape.
Buy this Report @ https://brandessenceresearch.biz/Buy/Create?ResearchPostId=65812&RequestType=Buy&PurchasePlan=SingleUser
Chemotherapy Induced Peripheral Neuropathy Treatment Market Segmentation –
By Type
Calcium Channel a2-delta Ligands
Antidepressants
Opioids
Others
By Application
Platinum Agents
Taxanes
Vinca Alkaloids
Others
By Regional & Country Analysis:
North America
U.S.
Canada
Europe
U.K.
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
Mexico
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY TREATMENT Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY TREATMENT Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY TREATMENT Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
3. Chapter – Global CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY TREATMENT Market Overview: Quantitative Analysis
4. Chapter – Global CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY TREATMENT Market Analysis: By Modes of Transportation
5. Chapter – Global CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY TREATMENT Market Analysis: By Applications Type
6. Chapter – Global CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY TREATMENT Market Analysis: By End-Use Industry
7. Chapter – Global CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY TREATMENT Market Analysis: By Manufacturer
9. Chapter – Company Profiles
9.1. Aptinyx
9.1.1. Overview
9.1.2. Financials
9.1.3. Product portfolio
9.1.4. CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY TREATMENT Market Revenue (USD Million) and Market Share (%), 2014 – 2018
9.1.5. CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY TREATMENT Sales Market Share (%), 2014 – 2018
9.1.6. Business strategy
9.1.7. Recent developments
9.2. Aptinyx
9.3. AsahiKaseiPharma
9.4. RegenacyPharmaceuticals
9.5. MAKScientific
9.6. MetysPharmaceuticals
9.7. NemusBioscience
9.8. PledPharma
9.9. SovaPharmaceuticals
9.10. DermaXon
9.11. ImmunePharmaceuticals
9.12. Kineta
9.13. KrenitskyPharmaceuticals
9.14. PeriphaGen
9.15. ApexianPharma
9.16. WinSanTor
9.17. SolasiaPharma
9.18. Others
About us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at alan@brandessenceresearch.biz
Website: https://brandessenceresearch.biz
Related Report:
Medical Devices Industry Reports 2019
Mothballs Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025
Dibigatran Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025
Diarrhea Drug Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025
